Ledger.Open graph →
SEC Form D · Amendment · filed April 7, 2014

Daktari Diagnostics, Inc

Offering
$20.0M
Sold
$20.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Christopher Earl · Cambridge, MADirectorStanley Lapidus · Cambridge, MADirectorRoger Kitterman · Cambridge, MADirectorNancy E. Domaille · St Cloud, MNDirectorJason R. Ferche · St Cloud, MNDirectorGregory A. Schumacher · St Cloud, MNDirectorArthur R. Monaghan · St Cloud, MNExec · DirectorAlvin M. Kern · St Cloud, MNDirectorMichelle E. Bauerly Kopel · St Cloud, MNExec · DirectorKathleen D. Harris · Bostin, MADirectorJohn D. Dore · Boston, MADirectorS. D. Keesler · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗